Olipudase alfa for treating Niemann-Pick disease types A and B [ID3913]

This appeal hearing will hear appeals against the Final Draft Guidance for the above technology by the following organisations: 

  •  Niemann-Pick UK

The British Inherited Metabolic Diseases Group submitted an appeal letter, but their appeal was rejected during the scrutiny stage.

The appeal panel will convene on Friday 24 May 2024 at 10:00am via Zoom to hear oral representations from the appellants.